Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular

Clinical value of 18F-fluorodeoxyglucose PET-CT in patients with small- and medium-size vessel vasculitis, such as Wegener’s granulomatosis

Stefan Vöö, Michael Kemna, Pieter van Paassen, Jan-Willem Cohen Tervaert and Marinus van Kroonenburgh
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 353;
Stefan Vöö
1Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kemna
2Department of Internal Medicine, Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pieter van Paassen
2Department of Internal Medicine, Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan-Willem Cohen Tervaert
2Department of Internal Medicine, Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marinus van Kroonenburgh
1Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 53 no. supplement 1 353

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2012

Author Information

  1. Stefan Vöö1,
  2. Michael Kemna2,
  3. Pieter van Paassen2,
  4. Jan-Willem Cohen Tervaert2 and
  5. Marinus van Kroonenburgh1
  1. 1Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands
  2. 2Department of Internal Medicine, Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, Netherlands

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 20141600
Dec 2014100
Jun 2015900
Jul 2015300
Sep 2015500
Oct 2015300
Jan 2016100
Feb 2016500
Mar 2016200
Jun 2016100
Jul 2016400
Aug 2016400
Sep 2016400
Oct 2016100
Nov 2016400
Dec 2016700
Jan 20171200
Feb 2017600
Apr 2017400
May 2017300
Jun 2017600
Jul 2017100
Aug 2017200
Sep 2017300
Oct 2017400
Dec 2017200
Jan 2018900
Feb 2018500
Mar 2018700
Apr 2018900
May 2018800
Jun 2018300
Sep 20181800
Oct 2018900
Nov 2018700
Dec 2018600
Jan 20191200
Feb 2019800
Mar 2019100
Apr 20192200
May 2019600
Jun 2019500
Jul 2019600
Aug 2019400
Sep 20191200
Oct 2019600
Nov 2019500
Dec 2019300
Jan 2020700
Feb 2020900
Mar 20201700
Apr 20202000
May 2020400
Jun 2020400
Jul 20201900
Aug 20201700
Sep 20201400
Oct 20201900
Nov 20201900
Dec 20201500
Jan 20211000
Feb 20211500
Mar 20211500
Apr 20211600
May 20211600
Jun 20211300
Jul 20211200
Aug 20212000
Sep 20212200
Oct 20211500
Nov 20215100
Dec 20211700
Jan 20223500
Feb 20221500
Mar 20221100
Apr 20226200
May 20221600
Jun 2022200
Jul 2022800
Aug 2022200
Sep 2022400
Nov 2022300
Dec 2022400
Jan 2023500
Feb 2023200
Mar 2023700
Apr 2023500
May 2023300
Jun 2023300
Jul 2023100
Aug 2023700
Sep 2023100
Oct 20231000
Nov 2023100
Dec 2023400
Jan 2024500
Feb 2024100
Mar 2024300
Apr 2024400
May 2024800
Jun 20241100
Jul 20241700
Aug 20241300
Sep 2024200
Oct 2024800
Nov 2024900
Dec 2024700
Jan 2025400
Feb 2025500
Mar 2025900
Apr 2025800
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical value of 18F-fluorodeoxyglucose PET-CT in patients with small- and medium-size vessel vasculitis, such as Wegener’s granulomatosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical value of 18F-fluorodeoxyglucose PET-CT in patients with small- and medium-size vessel vasculitis, such as Wegener’s granulomatosis
Stefan Vöö, Michael Kemna, Pieter van Paassen, Jan-Willem Cohen Tervaert, Marinus van Kroonenburgh
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 353;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical value of 18F-fluorodeoxyglucose PET-CT in patients with small- and medium-size vessel vasculitis, such as Wegener’s granulomatosis
Stefan Vöö, Michael Kemna, Pieter van Paassen, Jan-Willem Cohen Tervaert, Marinus van Kroonenburgh
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 353;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular

  • Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
  • Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial
  • Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
Show more Cardiovascular

Assessing the Role of Inflammation, Sympathetic Innervation & Coronary Flow Reserve in CD

  • BNP is an independent predictor of chemotherapy-related cardiotoxicity and death: Comparison with gated equilibrium radionuclide ventriculography
  • 18F-FDG-PET/CT based management of patients with Takayasu arteritis
  • Adaptive servo-ventilation therapy can improve cardiac sympathetic nerve activity, cardiac function, exercise capacity and symptom in chronic heart failure patients
Show more Assessing the Role of Inflammation, Sympathetic Innervation & Coronary Flow Reserve in CD

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire